Stevanato Group S.p.A. (NYSE:STVN) Shares Purchased by Hardy Reed LLC

Hardy Reed LLC boosted its stake in shares of Stevanato Group S.p.A. (NYSE:STVN) by 8.2% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 11,077 shares of the company’s stock after purchasing an additional 840 shares during the period. Hardy Reed LLC’s holdings in Stevanato Group were worth $222,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Hilltop National Bank raised its position in shares of Stevanato Group by 34.3% in the 2nd quarter. Hilltop National Bank now owns 4,395 shares of the company’s stock worth $81,000 after buying an additional 1,122 shares during the period. nVerses Capital LLC acquired a new stake in Stevanato Group during the third quarter worth about $84,000. Harbor Capital Advisors Inc. raised its holdings in shares of Stevanato Group by 109.1% in the 2nd quarter. Harbor Capital Advisors Inc. now owns 8,867 shares of the company’s stock worth $163,000 after purchasing an additional 4,626 shares during the period. Raymond James Trust N.A. lifted its stake in shares of Stevanato Group by 18.7% in the 2nd quarter. Raymond James Trust N.A. now owns 10,239 shares of the company’s stock valued at $188,000 after purchasing an additional 1,613 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. grew its holdings in shares of Stevanato Group by 59.2% during the 2nd quarter. Oppenheimer Asset Management Inc. now owns 11,941 shares of the company’s stock worth $219,000 after purchasing an additional 4,441 shares during the period.

Stevanato Group Trading Up 0.6 %

Shares of NYSE STVN opened at €20.04 ($21.09) on Wednesday. The company has a quick ratio of 1.21, a current ratio of 1.81 and a debt-to-equity ratio of 0.22. Stevanato Group S.p.A. has a 1-year low of €16.56 ($17.43) and a 1-year high of €34.73 ($36.56). The business has a 50-day moving average of €19.45 and a 200-day moving average of €19.64.

Stevanato Group (NYSE:STVN) last released its quarterly earnings results on Tuesday, November 5th. The company reported €0.12 ($0.13) earnings per share for the quarter, missing analysts’ consensus estimates of €0.13 ($0.14) by (€0.01) (($0.01)). Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. The company had revenue of €277.90 million during the quarter, compared to analysts’ expectations of €274.36 million. During the same quarter in the prior year, the company earned $0.16 EPS. The firm’s revenue was up 2.4% compared to the same quarter last year. As a group, equities analysts anticipate that Stevanato Group S.p.A. will post 0.5 EPS for the current year.

Wall Street Analyst Weigh In

Separately, Citigroup decreased their price objective on shares of Stevanato Group from $30.00 to $28.00 and set a “buy” rating for the company in a research note on Wednesday, August 7th.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.